Clinical Trials Logo
  1. Home
  2. Ventricular Dysfunction, Left
  3. NCT01936649

Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.

Ventricular Dysfunction, Left Clinical Trial

Official title:
A Phase 4, Open-label Test-retest Study to Assess the Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView (Iobenguane I 123 Injection)

Clinical Trial Summary

The aim of the study is to assess the reproducibility of quantitative measurements of myocardial uptake of Iobenguane I 123 on planar and SPECT imaging following intravenous (iv.) administration of AdreView. Efficacy will be assessed based upon the absolute differences between quantitative analyses of imaging data on 2 scans performed 5 to 14 days apart.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01936649
Study type Interventional
Source GE Healthcare
Contact
Status Completed
Phase Phase 4
Start date February 2014
Completion date February 2014
View Details
See also
  Status Clinical Trial Phase
Completed NCT01959828 - Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac Surgery Phase 3
Recruiting NCT03385785 - Ventriculo-arterial Coupling Modification Evaluated by PRAM During TAVI Procedure N/A
Completed NCT01780727 - Echo-guided Hemodynamic Management Strategy in Elderly Patients Undergoing Noncardiac Surgery N/A
Completed NCT02428894 - Characterization of the Plasma Proteome Following Left Ventricular Assist Device Implantation N/A
Completed NCT02147457 - Prematurity as Predictor of Children's Cardiovascular-renal Health N/A
Completed NCT00391846 - Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone Phase 4
Enrolling by invitation NCT03701997 - Registry to Monitor Berlin Heart EXCOR® Pediatric VAD as a Bridge to Cardiac Transplantation.
Not yet recruiting NCT05784051 - Prophylactic Frequent Premature Ventricular complexeS sUPPression on Left ventriculaR Function impairmEnt in aSymptomatic patientS Phase 4
Recruiting NCT04939077 - Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC) Phase 1/Phase 2
Terminated NCT01065051 - Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics Phase 2
Terminated NCT00587990 - Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) Phase 1/Phase 2
Completed NCT02972918 - Preoperative levosimendán and Hip Fracture
Completed NCT00303979 - IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting
Withdrawn NCT02155842 - Exercise Training in Treating Diastolic Heart Failure N/A
Completed NCT00385242 - PET and Recovery Following Revascularization (PARR 2) Phase 3
Terminated NCT01172756 - A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic Dysfunction Phase 2
Completed NCT02899897 - Place of Echocardiography in IV Fluid Therapy in Patients With Septic Shock and Left Ventricular Systolic Dysfunction
Completed NCT02668419 - Electrical Stimulation Improves Exercise Tolerance in Patients With Advanced Heart Failure on Continuous Dobutamine Use N/A
Completed NCT01800292 - Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH. Phase 4
Completed NCT00143507 - The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction Phase 3